Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin
- PMID: 12543661
- PMCID: PMC151770
- DOI: 10.1128/AAC.47.2.568-576.2003
Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin
Abstract
Many VISA (vancomycin intermediately resistant Staphylococcus aureus) strains are characterized by increased cell wall biosynthesis and decreased cross-linking of the peptide side chains, leading to accumulation of free D-alanyl-D-alanine termini in the peptidoglycan, which act as false target sites for vancomycin. A spontaneous mutant of methicillin-resistant VISA strain SA137/93A (vancomycin MIC [E-test], 8 micro g/ml), called SA137/93G, showed increased resistance to vancomycin (MIC [E-test], 12 micro g/ml). Analysis of the resistance profile of the mutant revealed a loss of beta-lactam resistance with a concomitant increase in resistance to glycopeptides. In both strains, cell wall thickness was 1.4-fold greater than that of control isolates. However, cross-linking of the cell wall was drastically lower in SA137/93A than in SA137/93G. The sensitivity of strain SA137/93G to beta-lactams was due to loss of the beta-lactamase plasmid and a deletion that comprises 32.5 kb of the methicillin resistance cassette SCCmec, as well as 65.4 kb of chromosomal DNA. A spontaneous mutant of SA137/93G with higher sensitivity to vancomycin displayed a cell wall profile similar, in some respects, to that of an fmhB mutant. Results described here and elsewhere show that the only feature common to all VISA strains is a thickened cell wall, which may play a central role in the vancomycin resistance mechanism.
Figures






Similar articles
-
Production of capsular polysaccharide does not influence Staphylococcus aureus vancomycin susceptibility.BMC Microbiol. 2013 Mar 22;13:65. doi: 10.1186/1471-2180-13-65. BMC Microbiol. 2013. PMID: 23522028 Free PMC article.
-
Role of the msaABCR Operon in Cell Wall Biosynthesis, Autolysis, Integrity, and Antibiotic Resistance in Staphylococcus aureus.Antimicrob Agents Chemother. 2019 Sep 23;63(10):e00680-19. doi: 10.1128/AAC.00680-19. Print 2019 Oct. Antimicrob Agents Chemother. 2019. PMID: 31307991 Free PMC article.
-
Role of insertion elements and yycFG in the development of decreased susceptibility to vancomycin in Staphylococcus aureus.Int J Med Microbiol. 2007 Jul;297(4):205-15. doi: 10.1016/j.ijmm.2007.02.002. Epub 2007 Apr 5. Int J Med Microbiol. 2007. PMID: 17418637
-
Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus.Emerg Infect Dis. 2001 Mar-Apr;7(2):327-32. doi: 10.3201/eid0702.010237. Emerg Infect Dis. 2001. PMID: 11294734 Free PMC article. Review.
-
Glycopeptide resistance in Staphylococcus aureus: is it a real threat?J Infect Chemother. 2004 Apr;10(2):69-75. doi: 10.1007/s10156-004-0307-5. J Infect Chemother. 2004. PMID: 15160298 Review.
Cited by
-
Production of capsular polysaccharide does not influence Staphylococcus aureus vancomycin susceptibility.BMC Microbiol. 2013 Mar 22;13:65. doi: 10.1186/1471-2180-13-65. BMC Microbiol. 2013. PMID: 23522028 Free PMC article.
-
Vancomycin-intermediate Staphylococcus aureus strains have impaired acetate catabolism: implications for polysaccharide intercellular adhesin synthesis and autolysis.Antimicrob Agents Chemother. 2007 Feb;51(2):616-22. doi: 10.1128/AAC.01057-06. Epub 2006 Nov 27. Antimicrob Agents Chemother. 2007. PMID: 17130298 Free PMC article.
-
tcaA inactivation increases glycopeptide resistance in Staphylococcus aureus.Antimicrob Agents Chemother. 2004 Jun;48(6):1953-9. doi: 10.1128/AAC.48.6.1953-1959.2004. Antimicrob Agents Chemother. 2004. PMID: 15155184 Free PMC article.
-
Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300.PLoS Pathog. 2012 Feb;8(2):e1002505. doi: 10.1371/journal.ppat.1002505. Epub 2012 Feb 2. PLoS Pathog. 2012. PMID: 22319446 Free PMC article.
-
Combination prophylactic therapy with rifampin increases efficacy against an experimental Staphylococcus epidermidis subcutaneous implant-related infection.Antimicrob Agents Chemother. 2014;58(4):2377-86. doi: 10.1128/AAC.01943-13. Epub 2014 Feb 10. Antimicrob Agents Chemother. 2014. PMID: 24514089 Free PMC article.
References
-
- Avison, M. B., P. M. Bennett, R. A. Howe, and T. R. Walsh. 2002. Preliminary analysis of the genetic basis for vancomycin resistance in Staphylococcus aureus strain Mu50. J. Antimicrob. Chemother. 49:255-260. - PubMed
-
- Bierbaum, G., K. Fuchs, W. Lenz, C. Szekat, and H.-G. Sahl. 1999. Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany. Eur. J. Clin. Microbiol. Infect. Dis. 18:691-696. - PubMed
-
- Bobin-Dubreux, S., M.-E. Reverdy, C. Nervi, M. Rougier, A. Bolmström, F. Vandenesch, and J. Etienne. 2001. Clinical isolate of vancomycin-heterointermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative. Antimicrob. Agents Chemother. 45:349-352. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous